These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1715 related items for PubMed ID: 26004800

  • 1. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY.
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [Abstract] [Full Text] [Related]

  • 2. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [Abstract] [Full Text] [Related]

  • 3. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 4. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM.
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [Abstract] [Full Text] [Related]

  • 5. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
    Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N, Gandaglia G, Eastham JA, Scardino PT, Vickers A, Cozzarini C, Montorsi F, Briganti A.
    Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
    [Abstract] [Full Text] [Related]

  • 6. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
    Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD.
    Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
    [Abstract] [Full Text] [Related]

  • 7. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
    Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1493-9. PubMed ID: 22401922
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
    Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CAF, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM.
    Cancer; 2017 Jul 01; 123(13):2489-2496. PubMed ID: 28323339
    [Abstract] [Full Text] [Related]

  • 9. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.
    Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2013 Mar 15; 85(4):1012-7. PubMed ID: 22981709
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit.
    Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW.
    BJU Int; 2019 Feb 15; 123(2):252-260. PubMed ID: 29626845
    [Abstract] [Full Text] [Related]

  • 11. High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy.
    Ost P, Cozzarini C, De Meerleer G, Fiorino C, De Potter B, Briganti A, Nagler EV, Montorsi F, Fonteyne V, Di Muzio N.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):960-5. PubMed ID: 22172901
    [Abstract] [Full Text] [Related]

  • 12. Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
    Murgic J, Jaksic B, Prpic M, Kust D, Bahl A, Budanec M, Prgomet Secan A, Franco P, Kruljac I, Spajic B, Babic N, Kruslin B, Zovak M, Zubizarreta E, Rosenblatt E, Fröbe A.
    Radiat Oncol; 2021 May 12; 16(1):88. PubMed ID: 33980277
    [Abstract] [Full Text] [Related]

  • 13. Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.
    Naik M, Reddy CA, Stephans KL, Ciezki JP, Garcia J, Grivas P, Stephenson AJ, Klein EA, Tendulkar RD.
    Int J Radiat Oncol Biol Phys; 2016 Nov 01; 96(3):617-23. PubMed ID: 27681757
    [Abstract] [Full Text] [Related]

  • 14. Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up.
    Hajili T, Ohlmann CH, Linxweiler J, Niklas C, Janssen M, Siemer S, Stoeckle M, Saar M.
    BJU Int; 2019 Jan 01; 123(1):58-64. PubMed ID: 29772100
    [Abstract] [Full Text] [Related]

  • 15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 16. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
    Yoo S, You D, Kim YS, Hong JH, Ahn H, Kim CS.
    Urol Int; 2017 Mar 01; 99(4):406-413. PubMed ID: 29020683
    [Abstract] [Full Text] [Related]

  • 17. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
    Shilkrut M, Merrick GS, McLaughlin PW, Stenmark MH, Abu-Isa E, Vance SM, Sandler HM, Feng FY, Hamstra DA.
    Cancer; 2013 Feb 01; 119(3):681-90. PubMed ID: 22893254
    [Abstract] [Full Text] [Related]

  • 18. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G.
    Eur Urol; 2011 Oct 01; 60(4):842-9. PubMed ID: 21514039
    [Abstract] [Full Text] [Related]

  • 19. Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database.
    Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ.
    Eur Urol; 2014 Mar 01; 65(3):620-7. PubMed ID: 23245686
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer.
    Chen RC, Rosenman JG, Hoffman LG, Chiu WK, Wang AZ, Pruthi RS, Wallen EM, Crane JM, Kim WY, Rathmell WK, Godley PA, Whang YE.
    BJU Int; 2012 Dec 01; 110(11 Pt B):E721-6. PubMed ID: 23016517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.